Table 2.
Comparative study of the antibacterial efficiencies of the different composites.
Nano Composites | Conc. | % Reduction | Time (h) | Proposed Applications | Ref. | |
---|---|---|---|---|---|---|
E.coli | MRSA | |||||
BN/Ag | 70 mg/L | 100 | - | 3 | Eternal catalyst and antibacterial | [39] |
Gr-Pln | 5 mg/mL | - | 92 | - | Antibacterial applications | [40] |
BNAg/TiO2 | 2 mg/mL | 100 | - | 3 | Photodegradation and antibacterial applications | [41] |
Cu-Go/hBN | - | 100 | - | 24 | Biology and medical applications | [42] |
PEI/BNNT | 1 mg/mL | 95 | 90 | 2 | Nano vector for targeted drug delivery system | [43] |
PHA/GAg | - | 82 | 60 | 2 | Antibacterial and sanitization application | [26] |
PHA/Ch-hBN | 1 mg/mL | 92 | 97 | 2 | Antibacterial and biological applications | This study |